PXD025568 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | A single immunization with CAF08 provides newborns with Th1-mediated protection against Respiratory Syncytial Virus infection |
Description | Respiratory Syncytial Virus (RSV) is a leading cause of morbidity and mortality in children, due in part to their distinct immune system, characterized by impaired induction of T-helper 1 (Th1)‐immunity. Here we describe cationic adjuvant formulation (CAF)-08, a liposomal vaccine formulation tailored to induce Th1 immunity in early life via synergistic engagement of Toll-like Receptor 7/8 and the C-type lectin receptor Mincle. Quantitative phosphoproteomics applied to human dendritic cells revealed a key role for Protein Kinase C- for enhanced Th1 cytokine production in neonatal dendritic cells and identified signaling events resulting in antigen cross-presentation. In vivo, a single immunization at birth with CAF08-adjuvanted RSV pre-fusion antigen protected newborn mice from RSV infection through induction of antigen-specific CD8+ and Th1 cells. Overall, we describe a novel pediatric adjuvant formulation and characterize its mechanism of action providing a promising avenue for development of early life vaccines against RSV and other intracellular pathogens. |
HostingRepository | PRIDE |
AnnounceDate | 2022-06-14 |
AnnouncementXML | Submission_2022-06-14_13:37:40.890.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Simon van Haren |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | phosphorylated residue; monohydroxylated residue |
Instrument | Q Exactive |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2021-04-22 23:08:03 | ID requested | |
⏵ 1 | 2022-06-14 13:37:41 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: Human, Dendritic cell, vaccine, newborn, RSV |
Contact List
Simon van Haren |
contact affiliation | 1.Precision Vaccines Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, MA, USA. 2. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. |
contact email | simon.vanharen@childrens.harvard.edu |
lab head | |
Simon van Haren |
contact affiliation | Boston Children's Hospital |
contact email | simon.vanharen@childrens.harvard.edu |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/06/PXD025568 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD025568
- Label: PRIDE project
- Name: A single immunization with CAF08 provides newborns with Th1-mediated protection against Respiratory Syncytial Virus infection